3.25.2 html 73 147 1 false 19 0 false 6 false false R1.htm 0001 - Document - Document and Entity Information Sheet http://biolinerx.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 0002 - Statement - CONDENSED CONSOLIDATED INTERIM STATEMENTS OF FINANCIAL POSITION (UNAUDITED) Sheet http://biolinerx.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition CONDENSED CONSOLIDATED INTERIM STATEMENTS OF FINANCIAL POSITION (UNAUDITED) Statements 2 false false R3.htm 0003 - Statement - CONDENSED CONSOLIDATED INTERIM STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED) Sheet http://biolinerx.com/role/CondensedConsolidatedInterimStatementsOfComprehensiveLoss CONDENSED CONSOLIDATED INTERIM STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED) Statements 3 false false R4.htm 0004 - Statement - CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CHANGES IN EQUITY (UNAUDITED) Sheet http://biolinerx.com/role/CondensedInterimStatementsOfChangesInEquity CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CHANGES IN EQUITY (UNAUDITED) Statements 4 false false R5.htm 0005 - Statement - CONDENSED CONSOLIDATED INTERIM CASH FLOW STATEMENTS (UNAUDITED) Sheet http://biolinerx.com/role/CondensedConsolidatedInterimCashFlowStatements CONDENSED CONSOLIDATED INTERIM CASH FLOW STATEMENTS (UNAUDITED) Statements 5 false false R6.htm 0006 - Disclosure - GENERAL INFORMATION Sheet http://biolinerx.com/role/GeneralInformation GENERAL INFORMATION Notes 6 false false R7.htm 0007 - Disclosure - BASIS OF PREPARATION Sheet http://biolinerx.com/role/BasisOfPreparation BASIS OF PREPARATION Notes 7 false false R8.htm 0008 - Disclosure - MATERIAL ACCOUNTING POLICIES Sheet http://biolinerx.com/role/SignificantAccountingPolicies MATERIAL ACCOUNTING POLICIES Notes 8 false false R9.htm 0009 - Disclosure - AT-THE-MARKET ("ATM") SALES AGREEMENT WITH HCW Sheet http://biolinerx.com/role/At-the-marketAtmSalesAgreementWithBtig AT-THE-MARKET ("ATM") SALES AGREEMENT WITH HCW Notes 9 false false R10.htm 0010 - Disclosure - CONTINGENT LIABILITIES Sheet http://biolinerx.com/role/CommitmentsAndContingentLiabilities CONTINGENT LIABILITIES Notes 10 false false R11.htm 0011 - Disclosure - FINANCINGS Sheet http://biolinerx.com/role/EQUITYFINANCING FINANCINGS Notes 11 false false R12.htm 0012 - Disclosure - FAIR VALUE MEASUREMENT OF WARRANTS USING SIGNIFICANT UNOBSERVABLE INPUTS (LEVEL 3) Sheet http://biolinerx.com/role/FAIRVALUEMEASUREMENTOFWARRANTSUSINGSIGNIFICANTUNOBSERVABLEINPUTSLEVEL3 FAIR VALUE MEASUREMENT OF WARRANTS USING SIGNIFICANT UNOBSERVABLE INPUTS (LEVEL 3) Notes 12 false false R13.htm 0013 - Disclosure - SHAREHOLDERS' EQUITY Sheet http://biolinerx.com/role/ShareholdersEquity SHAREHOLDERS' EQUITY Notes 13 false false R14.htm 0014 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION Sheet http://biolinerx.com/role/SupplementaryFinancialStatementInformation SUPPLEMENTAL FINANCIAL INFORMATION Notes 14 false false R15.htm 9960701 - Disclosure - MATERIAL ACCOUNTING POLICIES (Policies) Sheet http://biolinerx.com/role/MATERIALACCOUNTINGPOLICIESPolicies MATERIAL ACCOUNTING POLICIES (Policies) Policies 15 false false R16.htm 9960702 - Disclosure - FAIR VALUE MEASUREMENT OF WARRANTS USING SIGNIFICANT UNOBSERVABLE INPUTS (LEVEL 3) (Tables) Sheet http://biolinerx.com/role/FAIRVALUEMEASUREMENTOFWARRANTSUSINGSIGNIFICANTUNOBSERVABLEINPUTSLEVEL3Tables FAIR VALUE MEASUREMENT OF WARRANTS USING SIGNIFICANT UNOBSERVABLE INPUTS (LEVEL 3) (Tables) Tables http://biolinerx.com/role/FAIRVALUEMEASUREMENTOFWARRANTSUSINGSIGNIFICANTUNOBSERVABLEINPUTSLEVEL3 16 false false R17.htm 9960703 - Disclosure - SHAREHOLDERS' EQUITY (Tables) Sheet http://biolinerx.com/role/ShareholdersEquityTables SHAREHOLDERS' EQUITY (Tables) Tables http://biolinerx.com/role/ShareholdersEquity 17 false false R18.htm 9960704 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION (Tables) Sheet http://biolinerx.com/role/SupplementaryFinancialStatementInformationTables SUPPLEMENTAL FINANCIAL INFORMATION (Tables) Tables http://biolinerx.com/role/SupplementaryFinancialStatementInformation 18 false false R19.htm 9960705 - Disclosure - GENERAL INFORMATION (Narrative) (Details) Sheet http://biolinerx.com/role/GENERALINFORMATIONNarrativeDetails GENERAL INFORMATION (Narrative) (Details) Details http://biolinerx.com/role/GeneralInformation 19 false false R20.htm 9960706 - Disclosure - AT-THE-MARKET ("ATM") SALES AGREEMENT WITH HCW (Narrative) (Details) Sheet http://biolinerx.com/role/At-the-marketAtmSalesAgreementWithBtigDetails AT-THE-MARKET ("ATM") SALES AGREEMENT WITH HCW (Narrative) (Details) Details http://biolinerx.com/role/At-the-marketAtmSalesAgreementWithBtig 20 false false R21.htm 9960707 - Disclosure - CONTINGENT LIABILITIES (Narrative) (Details) Sheet http://biolinerx.com/role/CONTINGENTLIABILITIESDeatils CONTINGENT LIABILITIES (Narrative) (Details) Details http://biolinerx.com/role/CommitmentsAndContingentLiabilities 21 false false R22.htm 9960708 - Disclosure - FINANCINGS (Narrative) (Details) Sheet http://biolinerx.com/role/EQUITYFINANCINGNarrativeDetails FINANCINGS (Narrative) (Details) Details http://biolinerx.com/role/EQUITYFINANCING 22 false false R23.htm 9960709 - Disclosure - FAIR VALUE MEASUREMENT OF WARRANTS USING SIGNIFICANT UNOBSERVABLE INPUTS (LEVEL 3) (Details) Sheet http://biolinerx.com/role/FAIRVALUEMEASUREMENTOFWARRANTSUSINGSIGNIFICANTUNOBSERVABLEINPUTSLEVEL3Details FAIR VALUE MEASUREMENT OF WARRANTS USING SIGNIFICANT UNOBSERVABLE INPUTS (LEVEL 3) (Details) Details http://biolinerx.com/role/FAIRVALUEMEASUREMENTOFWARRANTSUSINGSIGNIFICANTUNOBSERVABLEINPUTSLEVEL3Tables 23 false false R24.htm 9960710 - Disclosure - SHAREHOLDERS' EQUITY (Schedule of Share Capital) (Details) Sheet http://biolinerx.com/role/ShareholdersEquityScheduleOfShareCapitalDetails SHAREHOLDERS' EQUITY (Schedule of Share Capital) (Details) Details http://biolinerx.com/role/ShareholdersEquityTables 24 false false R25.htm 9960711 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION (Narrative) (Details) Sheet http://biolinerx.com/role/SUPPLEMENTALFINANCIALINFORMATIONNarrative SUPPLEMENTAL FINANCIAL INFORMATION (Narrative) (Details) Details http://biolinerx.com/role/SupplementaryFinancialStatementInformationTables 25 false false R26.htm 9960712 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION (Schedule of Cost of revenues) (Details) Sheet http://biolinerx.com/role/SUPPLEMENTARYFINANCIALSTATEMENTINFORMATIONScheduleOfCostOfRevenuesDetails SUPPLEMENTAL FINANCIAL INFORMATION (Schedule of Cost of revenues) (Details) Details http://biolinerx.com/role/SupplementaryFinancialStatementInformationTables 26 false false All Reports Book All Reports blrx-20250630.xsd blrx-20250630_cal.xml blrx-20250630_def.xml blrx-20250630_lab.xml blrx-20250630_pre.xml zk2533581.htm exhibit_2.htm http://xbrl.sec.gov/dei/2025 https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full true true